Li Shen Loo

1.6k citations

24 papers · 993 · h-index 17

Impact in

Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ
- Cellular transport and secretion
Psychiatry and Mental health top 10%
- Migraine and Headache Studies

Papers in

Molecular Biology 9
Psychiatry and Mental health 8
- Migraine and Headache Studies 8

Co-authors: Wanjin Hong (9 shared papers)Chun Jye Lim (1 shared paper)Yaan Fun Chong (1 shared paper)Siew Wee Chan (1 shared paper)Caixia Huang (1 shared paper)Yan Shan Ong (2 shared papers)Gavin S. Dawe (1 shared paper)Muthafar Al‐Haddawi (1 shared paper)
Journals: The Journal of Headache and Pain (3 papers)Nature Communications (2 papers)The Journal of Clinical Pharmacology (2 papers)The Journal of Cell Biology (1 paper)Scientific Reports (1 paper)
Partner nations: United States Singapore Germany

In The Last Decade

Li Shen Loo

24 papers receiving 977 citations

Peers

Countries citing papers authored by Li Shen Loo

Since Specialization

Citations

This map shows the geographic impact of Li Shen Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Shen Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Shen Loo more than expected).

Fields of papers citing papers by Li Shen Loo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Shen Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Shen Loo. The network helps show where Li Shen Loo may publish in the future.

Co-authors

The 25 scholars most cited alongside Li Shen Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Li Shen Loo Line = papers co-authored together Li Shen Loo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation Journal of Biological Chemistry ·Siew Wee Chan, Chun Jye Lim, Li Shen Loo, Yaan Fun Chong, Caixia Huang, Wanjin Hong	2009	216
2	An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma Nature Communications ·Sayan Chakraborty, Manikandan Lakshmanan, Hannah L. F. Swa, Jianxiang Chen, Xiaoqian Zhang, Yan Shan Ong, Li Shen Loo, Semih Can Akıncılar, Jayantha Gunaratne, Vinay Tergaonkar, Kam M. Hui, Wanjin Hong	2015	126
3	Deficiency of Sorting Nexin 27 (SNX27) Leads to Growth Retardation and Elevated Levels of N-Methyl-d-Aspartate Receptor 2C (NR2C) Molecular and Cellular Biology ·Lei Cai, Li Shen Loo, Vadim Atlashkin, Brendon J. Hanson, Wanjin Hong	2011	81
4	A role for sorting nexin 27 in AMPA receptor trafficking Nature Communications ·Li Shen Loo, Ning Tang, Muthafar Al‐Haddawi, Gavin S. Dawe, Wanjin Hong	2014	80
5	Imaging synaptic inhibition in transgenic mice expressing the chloride indicator, Clomeleon PubMed ·Ken Berglund, Wolfram Schleich, Patrik Krieger, Li Shen Loo, Dongqing Wang, Nell B. Cant, Guoping Feng, George J Augustine, Thomas Kuner	2006	67
6	p125A exists as part of the mammalian Sec13/Sec31 COPII subcomplex to facilitate ER-Golgi transport The Journal of Cell Biology ·Yan Shan Ong, Bor Luen Tang, Li Shen Loo, Wanjin Hong	2010	44
7	Sorting nexin 27 couples PTHR trafficking to retromer for signal regulation in osteoblasts during bone growth Molecular Biology of the Cell ·Audrey Chan, Thomas Clairfeuille, Euphemie Landao‐Bassonga, Genevieve Kinna, Pei Ying Ng, Li Shen Loo, Tak Sum Cheng, Minghao Zheng, Wanjin Hong, Rohan D. Teasdale, Brett M. Collins, Nathan J. Pavlos	2016	41
8	Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans Cephalalgia ·Kerry Knievel, Andrew Buchanan, Louise Lombard, Simin Baygani, Joel Raskin, John H. Krege, Li Shen Loo, Mika Komori, Joshua Tobin	2019	40
9	Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review Advances in Therapy ·Élizabeth Leroux, Andrew Buchanan, Louise Lombard, Li Shen Loo, Daisy Bridge, B Rousseau, Natasha Hopwood, Brandy R. Matthews, Uwe Reuter	2020	39
10	A role for endobrevin/VAMP8 in CTL lytic granule exocytosis European Journal of Immunology ·Li Shen Loo, Le‐Ann Hwang, Yao Min Ong, Hock Soon Tay, Cheng‐Chun Wang, Wanjin Hong	2009	35
11	Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials The Lancet Neurology ·Xavier Montalbán, Patrick Vermersch, Douglas L. Arnold, Amit Bar‐Or, Bruce Cree, Anne H. Cross, Eva Havrdová, Ludwig Kappos, Olaf Stüve, Heinz Wiendl, Jerry S. Wolinsky, Frank Dahlke, Claire Le Bolay, Li Shen Loo, Sathej Gopalakrishnan, Yann Hyvert, Andrija Javor, Hans Guehring, Nadia Tenenbaum, Davorka Tomic, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	32
12	Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study The Journal of Headache and Pain ·Richard B. Lipton, Louise Lombard, Dustin Ruff, John H. Krege, Li Shen Loo, Andrew Buchanan, Thomas Melby, Dawn C. Buse	2020	30
13	Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials The Journal of Headache and Pain ·Li Shen Loo, Jessica Ailani, Jack Schim, Simin Baygani, Hans‐Peter Hundemer, Martha Port, John H. Krege	2019	30
14	Cortical expression of endothelin receptor subtypes A and B following middle cerebral artery occlusion in rats Neuroscience ·Li Shen Loo, Yen Kaow Ng, Yi Zhun Zhu, H.-S Lee, Peiyan Wong	2002	29
15	Participation of Tom1L1 in EGF-stimulated endocytosis of EGF receptor The EMBO Journal ·Ning Sheng Liu, Li Shen Loo, Eva Loh, Li‐Fong Seet, Wanjin Hong	2009	26
16	Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN) BMC Neurology ·Li Shen Loo, Brian M. Plato, Ira Turner, Michael Case, Joel Raskin, Sherie A. Dowsett, John H. Krege	2019	24
17	Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study The Journal of Clinical Pharmacology ·Darren Wilbraham, Paul H. Berg, Max Tsai, Emily Liffick, Li Shen Loo, Erin Doty, Edward M. Sellers	2019	22
18	SNX27 links DGKζ to the control of transcriptional and metabolic programs in T lymphocytes Scientific Reports ·María Tello‐Lafoz, Cristina Rodríguez‐Rodríguez, Genevieve Kinna, Li Shen Loo, Wanjin Hong, Brett M. Collins, Rohan D. Teasdale, Isabel Mérida	2017	14
19	Impaired Volume Regulation is the Mechanism of Excitotoxic Sensitization to Complement Journal of Neuroscience ·Li Shen Loo, James O McNamara	2006	7
20	Efficacy and safety outcomes of dulaglutide by baseline HbA1c : A post hoc analysis of the REWIND trial Diabetes Obesity and Metabolism ·Edward Franek, Hertzel C. Gerstein, Matthew C. Riddle, Claudia Nicolay, Ana Hickey, Fady T. Botros, Li Shen Loo	2022	4

About Li Shen Loo

Li Shen Loo is a scholar working on Molecular Biology, Psychiatry and Mental health, Cell Biology, Pathology and Forensic Medicine and Surgery, having authored 24 papers that have together received 993 indexed citations. Recurring topics across this work include Migraine and Headache Studies (8 papers), Trigeminal Neuralgia and Treatments (6 papers), Neuroscience and Neuropharmacology Research (4 papers), Cellular transport and secretion (4 papers), Cardiovascular Syncope and Autonomic Disorders (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers), Diabetes Treatment and Management (3 papers) and Pancreatic function and diabetes (2 papers). The work is most often cited by research in Cell Biology (428 citations), Psychiatry and Mental health (185 citations), Cellular and Molecular Neuroscience (159 citations), Pathology and Forensic Medicine (157 citations) and Molecular Biology (483 citations). Li Shen Loo has collaborated with scholars based in United States, Singapore and Germany. Frequent co-authors include Wanjin Hong, Chun Jye Lim, Yaan Fun Chong, Siew Wee Chan, Caixia Huang, Yan Shan Ong, Gavin S. Dawe, Muthafar Al‐Haddawi, Brendon J. Hanson and John H. Krege. Their work appears in journals such as The Journal of Headache and Pain, Nature Communications, The Journal of Clinical Pharmacology, The Journal of Cell Biology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Li Shen Loo

Impact in

Papers in i

In The Last Decade

Li Shen Loo

Peers

Countries citing papers authored by Li Shen Loo

Fields of papers citing papers by Li Shen Loo

All Works

About Li Shen Loo

Explore authors with similar magnitude of impact

Papers in